Spruce Biosciences, Inc. Common Stock

SPRB US85209E1091

💰
Capitalization
Small-cap

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT), and Tildacerfont/ Cortibon, a Companion Diagnostic, developed in partnership with HMNC Brain Health.

🔗
Website
https://www.sprucebiosciences.com
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
5
🙍
Insiders
2
Person Price Shares Total Published Completed
Parkman Healthcare Partners Llc
O 		17.91
USD 		256
Bought 		4,585
USD 		06/10/2025 06/10/2025
Parkman Healthcare Partners Llc
O 		19.33
USD 		232
Sold 		4,484
USD 		06/10/2025 06/10/2025
Parkman Healthcare Partners Llc
O 		17.46
USD 		25
Sold 		436
USD 		06/10/2025 06/10/2025
Novo Holdings A/s
 0.75
USD 		465,021
Sold 		350,951
USD 		21/03/2024 21/03/2024
Novo Holdings A/s
 0.73
USD 		359,979
Sold 		264,081
USD 		18/03/2024 20/03/2024
Novo Holdings A/s
 0.76
USD 		593,000
Sold 		447,715
USD 		18/03/2024 19/03/2024
Novo Holdings A/s
 0.77
USD 		842,020
Sold 		647,008
USD 		18/03/2024 18/03/2024
Novo Holdings A/s
 0.89
USD 		1,912,316
Sold 		1,698,902
USD 		14/03/2024 14/03/2024
Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Spruce Biosciences, Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Last 52W Low 52W High All-Time Low All-Time High β
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Novo Holdings A/s 5 3,408,656.64 681,731.33 14/03/2024 21/03/2024
Parkman Healthcare Partners Llc 3 9,505.27 3,168.42 06/10/2025 06/10/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Connected Companies 3
Name ISIN Ticker
IO Biotech, Inc. Common Stock US4497781090 IOBT

3 the firms where the current insiders have executed transactions.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.